Anti-GDNF Antibody

(No reviews yet) Write a Review
SKU:
STPA00090
Antibody Type:
Polyclonal
Applications:
WB
Reactivity:
Human
Reactivity:
Mouse
Reactivity:
Rat
Host Species:
Rabbit
  • Western blot analysis with anti-GDNF polyclonal antibody (STPA00090) showing detection of human recombinant GDNF protein (SinoBiological 10561-HNAE). This recombinant protein has a predicted molecular weight of 15.2 kDa. Block: 5% skim milk. Primary Antibody: Rabbit Anti-GDNF Polyclonal Antibody (STPA00090) at 1:5000 for 2 hours at RT. Secondary Antibody: Goat anti-rabbit IgG:HRP at 1:5000 for 1 hour at RT.
  • Western blot analysis with anti-GDNF polyclonal antibody (STPA00090) showing detection of GDNF protein in rat brain lysate (prepared in-house). Rat GNDF protein with signal and pro-peptide segments has a predicted molecular weight of 23.6 kDa (UniProt Q07731). Block: 5% skim milk. Primary Antibody: Rabbit Anti-GDNF Polyclonal Antibody (STPA00090) at 1:1000 for 2 hours at RT.
Frequently bought together:

Description

GDNF Antibody

GDNF Antibody is a rabbit polyclonal antibody directed against GDNF, offered by Assay Genie for research applications. Reported applications include WB. Reported reactivity: Human, Mouse and Rat. Purified by Protein A.

Glial cell line-derived neurotrophic factor (GDNF) is a highly conserved, secreted protein essential for neuronal survival, differentiation, and regeneration in both the central and peripheral nervous systems. As the founding member of the GDNF family ligands (GFLs), GDNF exerts its biological effects through a receptor complex composed of GFRα1 and the RET tyrosine kinase. This interaction is facilitated by the mature GDNF protein, which is generated from a 211-residue precursor (pro-GDNF) via proteolytic cleavage and structural stabilization through disulfide bonding and glycosylation. GDNF is widely expressed by neurons, glial cells, and skeletal muscle, particularly during development and in response to injury. It plays a critical role in supporting midbrain dopaminergic neurons, enhancing dopamine uptake, and promoting axonal growth. These properties have positioned GDNF as a promising therapeutic candidate in neurodegenerative diseases such as Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and synucleinopathies. Despite early evidence suggesting strong neuroprotective effects, recent studies have reported variable outcomes in disease models, highlighting the complexity of GDNF signaling and its context-dependent efficacy. Factors such as delivery method, receptor availability, and proteolytic processing may influence therapeutic outcomes. As research advances, GDNF remains a key focus in the development of neurorestorative strategies aimed at halting or reversing neuronal degeneration. Understanding its molecular mechanisms and optimizing its delivery are critical steps toward harnessing its full therapeutic potential. This antibody is also available conjugated to ATTO 390, ATTO 488, ATTO 594, APC, Biotin, FITC, HRP, PerCP and RPE. Supplied in 100 µg. For research use only; not for diagnostic or therapeutic procedures.

View AllClose

0 Reviews

View AllClose